U.S. Markets open in 1 hr 41 mins

Abbott’s Latest Valuation Metrics in April 2018

Sarah Collins
Abbott’s Latest Valuation Metrics in April 2018

On April 6, 2018, Abbott Laboratories (ABT) was trading at a forward PE (price-to-earnings ratio) of 20.1x, while its PE was 57.6x. A lower forward estimate compared to the current PE represents analysts’ expectations that a company will generate higher earnings over the next 12 months.